Wed. Oct 20th, 2021

The global “Peptic Ulcer Drugs Market” is projected to showcase exponential growth by reaching USD 5.13 billion by 2027 while exhibiting a CAGR of 2.4% between 2020 and 2027. This is attributable to the increasing prevalence of peptic ulcer disease and the growing demand for effective peptic ulcer drugs across the globe. Fortune Business Insights, in its latest report, titled, “Peptic Ulcer Drugs Market Size, Share & COVID-19 Imapct Analysis, By Drugs Type (Proton Pump Inhibitor (PPI), H2 Antagonists, Antibiotics, and Others), By Ulcer Type (Gastric Ulcer and Duodenal Ulcer), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027.”, mentions that the market was valued at USD 4.25 billion in 2019 and is likely to gain momentum in the forthcoming years.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/peptic-ulcer-drugs-market-103483

Soaring Demand for Peptic Ulcer Drugs In spite of COVID-19 Pandemic

The COVID-19 pandemic has led to the halt of several industrial processes causing unprecedented economic loss. However, pharmaceutical companies are thriving in these difficult times owing to the increasing demand for medication drugs across the globe. Likewise, the demand for these ulcer drugs is experiencing considerable growth as major pharmaceutical companies are increasing their focus on R&D activities to develop new drugs and cater to the demand for the OTC drugs across several stores. The market is, therefore, expected to showcase positive growth during the forecast period.

List of the Companies Operating in the Global Market

  • AstraZeneca (Cambridge, United Kingdom)
  • Novartis AG (Basel, Switzerland)
  • Pfizer Inc. (New York, United States)
  • GlaxoSmithKline plc. (Brentford, United Kingdom)
  • Takeda Pharmaceutical Company Limited. (Tokyo, Japan)
  • Mylan Pharmaceuticals Inc. (Canonsburg, Pennsylvania, United States)
  • Abbott (Illinois, United States)
  • ZydusCadila (Gujrat, India)
  • Other Players

REGIONAL ANALYSIS

Increasing Incidence of Disease in North America to Aid Growth

Among all the regions, North America was worth USD 1.76 billion in 2019 and is expected to hold the highestmarket share in the forthcoming years. This is attributable to the increasing incidence of peptic ulcers in the U.S. that drives the demand for peptic ulcer drugs in the region. On the other hand, Europe is anticipated to hold the second position during the forecast period. This is ascribable to factors such as the rising healthcare expenditure in countries such as the U.K., France, and Germany between 2020 and 2027.

Quick Buy –  Peptic Ulcer Drugs Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/103483

COMPETITIVE LANDSCAPE:

Product Launches by Major Companies to Strengthen TheirPortfolios

The global peptic ulcer drugs market is mainly dominated by major companies such as Pfizer, Inc., and AstraZeneca. These companies are actively investing in R&D activities to introduce new products and maintain their dominance in the global marketplace. Furthermore, the other key players are adopting strategies such as collaboration, partnership, and merger and acquisition to maintain their presencein the fiercely competitive market during the forecast period.

Industry Development:

  • March 2020: RedHill Biopharma announced the commercial launch in the U.S. of Talicia, a capsule to treat H.pylori infection in patients. The announcement by the leading pharma company is expected to strengthen its market position in the near future.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/peptic-ulcer-drugs-market-103483

Segments Covered in the Report

By Drug Type

  • Proton Pump Inhibitors
  • H2 Antagonists
  • Antibiotics
  • Others

By Ulcer Type

  • Gastric Ulcer
  • Duodenal Ulcer

By End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • By Drug Type
    • By Ulcer Type
    • By End User
    • By Country

Table of Content:

1 Peptic Ulcer Drugs Market Overview

1.1 Peptic Ulcer Drugs Product Overview

1.2 Peptic Ulcer Drugs Market Segment by Type

1.3 Global Peptic Ulcer Drugs Market Size by Type (2015-2027)

1.3.1 Global Peptic Ulcer Drugs Market Size Overview by Type (2015-2027)

1.3.2 Global Peptic Ulcer Drugs Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Peptic Ulcer Drugs Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Peptic Ulcer Drugs Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Peptic Ulcer Drugs Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Peptic Ulcer Drugs Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Peptic Ulcer Drugs Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Peptic Ulcer Drugs Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Peptic Ulcer Drugs Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Peptic Ulcer Drugs Sales Breakdown by Type (2015-2027)

1.4.2 Europe Peptic Ulcer Drugs Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Peptic Ulcer Drugs Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Peptic Ulcer Drugs Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Peptic Ulcer Drugs Sales Breakdown by Type (2015-2027)

2 Global Peptic Ulcer Drugs Market Competition by Company

2.1 Global Top Players by Peptic Ulcer Drugs Sales (2015-2021)

2.2 Global Top Players by Peptic Ulcer Drugs Revenue (2015-2021)

2.3 Global Top Players Peptic Ulcer Drugs Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Peptic Ulcer Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Peptic Ulcer Drugs Market Competitive Situation and Trends

2.5.1 Peptic Ulcer Drugs Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Peptic Ulcer Drugs Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptic Ulcer Drugs as of 2019)

2.7 Date of Key Company Enter into Peptic Ulcer Drugs Market

2.8 Key Company Peptic Ulcer Drugs Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Peptic Ulcer Drugs Status and Outlook by Region (2015-2027)

3.1 Global Peptic Ulcer Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Peptic Ulcer Drugs Market Size Market Share by Region (2015-2021)

3.2.1 Global Peptic Ulcer Drugs Sales Market Share by Region (2015-2021)

3.2.2 Global Peptic Ulcer Drugs Revenue Market Share by Region (2015-2021)

3.2.3 Global Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Peptic Ulcer Drugs Market Size Market Share by Region (2021-2027)

3.3.1 Global Peptic Ulcer Drugs Sales Market Share by Region (2021-2027)

3.3.2 Global Peptic Ulcer Drugs Revenue Market Share by Region (2021-2027)

3.3.3 Global Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Peptic Ulcer Drugs Market Size By Growth (2015-2027)

3.4.1 North America Peptic Ulcer Drugs Revenue By Growth (2015-2027)

3.4.2 North America Peptic Ulcer Drugs Sales By Growth (2015-2027)

3.5 Asia-Pacific Peptic Ulcer Drugs Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Peptic Ulcer Drugs Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Peptic Ulcer Drugs Sales By Growth (2015-2027)

3.6 Europe Peptic Ulcer Drugs Market Size By Growth (2015-2027)

3.6.1 Europe Peptic Ulcer Drugs Revenue By Growth (2015-2027)

3.6.2 Europe Peptic Ulcer Drugs Sales By Growth (2015-2027)

3.7 Latin America Peptic Ulcer Drugs Market Size By Growth (2015-2027)

3.7.1 Latin America Peptic Ulcer Drugs Revenue By Growth (2015-2027)

3.7.2 Latin America Peptic Ulcer Drugs Sales By Growth (2015-2027)

3.8 Middle East and Africa Peptic Ulcer Drugs Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Peptic Ulcer Drugs Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Peptic Ulcer Drugs Sales By Growth (2015-2027)

4 Global Peptic Ulcer Drugs by Application

4.1 Peptic Ulcer Drugs Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Peptic Ulcer Drugs Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Peptic Ulcer Drugs Historic Sales by Application (2015-2021)

4.4 Global Peptic Ulcer Drugs Forecasted Sales by Application (2021-2027)

4.5 Key Regions Peptic Ulcer Drugs Market Size by Application

4.5.1 North America Peptic Ulcer Drugs by Application

4.5.2 Europe Peptic Ulcer Drugs by Application

4.5.3 Asia-Pacific Peptic Ulcer Drugs by Application

4.5.4 Latin America Peptic Ulcer Drugs by Application

4.5.5 Middle East and Africa Peptic Ulcer Drugs by Application

5 North America Peptic Ulcer Drugs Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Peptic Ulcer Drugs Sales Market Share by Country (2015-2021)

5.1.2 North America Peptic Ulcer Drugs Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Peptic Ulcer Drugs Sales Market Share by Country (2021-2027)

5.2.2 North America Peptic Ulcer Drugs Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Peptic Ulcer Drugs Market Size By Growth (2015-2027)

5.3.2 Canada Peptic Ulcer Drugs Market Size By Growth (2015-2027)

6 Europe Peptic Ulcer Drugs Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Peptic Ulcer Drugs Sales Market Share by Country (2015-2021)

6.1.2 Europe Peptic Ulcer Drugs Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Peptic Ulcer Drugs Sales Market Share by Country (2021-2027)

6.2.2 Europe Peptic Ulcer Drugs Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Peptic Ulcer Drugs Market Size By Growth (2015-2027)

6.3.2 France Peptic Ulcer Drugs Market Size By Growth (2015-2027)

6.3.3 U.K. Peptic Ulcer Drugs Market Size By Growth (2015-2027)

6.3.4 Italy Peptic Ulcer Drugs Market Size By Growth (2015-2027)

6.3.5 Russia Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7 Asia-Pacific Peptic Ulcer Drugs Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Peptic Ulcer Drugs Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Peptic Ulcer Drugs Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Peptic Ulcer Drugs Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Peptic Ulcer Drugs Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.2 Japan Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.3 South Korea Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.4 India Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.5 Australia Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.6 Taiwan Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.7 Indonesia Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.8 Thailand Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.9 Malaysia Peptic Ulcer Drugs Market Size By Growth (2015-2027)

7.3.10 Philippines Peptic Ulcer Drugs Market Size By Growth (2015-2027)

Toc Continue…

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

 

Related Reports:

Top 5 Companies in the Peptic Ulcer Drugs Market, 2021 | Fortune Business Insights™

Top 5 Companies in the Ureteroscope Market, 2021 | Fortune Business Insights™

Top 5 Companies in the Vasopressin for Vasoplegic Shock Market, 2021 | Fortune Business Insights™

Top 5 Companies in the Allergic Conjunctivitis Market, 2021 | Fortune Business Insights™

Compounding Pharmacy Market Size Report 2021-2028 | Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Analysis

Top 5 Companies in the Vital Signs Monitoring Devices Market, 2021 | Fortune Business Insights™

Top 5 Companies in the Bovine Mastitis Market, 2021 | Fortune Business Insights™

Top 5 Companies in the Laser Hair Removal Market, 2021 | Fortune Business Insights™

Pharmacy Benefit Management Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Analysis

Vitality of Telemedicine in the Virtual Care Age

By umang.s

Leave a Reply

Your email address will not be published. Required fields are marked *